You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

1821 Results
Regimen
Cancer Type:
Hematologic, 
Myelodysplastic Syndrome (MDS)
Intent: Palliative
Funding:
Exceptional Access Program
    decitabine / cedazuridine - For the treatment of adult patients with myelodysplastic syndromes (MDS), according to clinical criteria
Regimen
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Intent: Palliative
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Hodgkin
Intent: Palliative
Funding:
ODB - General Benefit
    prednisone
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC in Combination with Chemotherapy - Indolent B-cell Lymphoma
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Indolent Lymphoma
Family physicians, nurse practitioners and nurses play a crucial role in cancer care, greatly influencing patients' participation in cancer screening...
Les médecins de famille, les infirmières praticiennes et les infirmières jouent un rôle essentiel dans la prestation des soins de cancérologie en...
Le dépistage du cancer du col de l’utérus permet de déceler des modifications cellulaires anormales avant qu’elles ne se transforment en cancer ou en...
Cette page s’adresse aux personnes porteuses d’un type de virus du papillome humain (VPH) pouvant parfois causer un cancer du col de l’utérus. Si...
Find information on what causes cervical cancer, the potential benefits and potential harms of regular cervical screening, cervical screening...

Pages